Testicular cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 32: Line 32:
* [[Malignant]]
* [[Malignant]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Unilateral
* [[Unilateral]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* History of [[cryptorchidism]]
* History of [[cryptorchidism]]
Line 40: Line 40:
* Does not occur during infancy
* Does not occur during infancy
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Late metastasis
* Late [[metastasis]]
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
* ALP  
* [[ALP]]
* C-KIT
* [[C-KIT]]
* CD30
* [[CD30]]
* EMA  
* EMA  
* Glycogen
* [[Glycogen]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Large cells wit watery cytoplasm
* Large cells wit watery [[cytoplasm]]
* Fried egg appearance
* Fried egg appearance
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Palpable, nontender unilateral testicular mass
* [[Palpable]], nontender unilateral [[testicular]] mass
* Usually homogeneous enlargement
* Usually [[homogeneous]] enlargement
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Elevated serum placental ALP (PALP)
* Elevated [[serum]] placental ALP (PALP)
| style="background: #F5F5F5; padding: 5px;" |Ultrasound:
| style="background: #F5F5F5; padding: 5px;" |Ultrasound:
* Homogeneous hypoechoic intratesticular mass
* Homogeneous hypoechoic intratesticular mass
Line 66: Line 66:
* [[Malignant]]
* [[Malignant]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Usually located in parenchyma of testis
* Usually located in [[parenchyma]] of [[testis]]
* May be nonpalpable
* May be nonpalpable
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Hemorrhagic]] mass with necrosis
* [[Hemorrhagic]] mass with [[necrosis]]
* Worse [[prognosis]] than [[seminoma]]
* Worse [[prognosis]] than [[seminoma]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 75: Line 75:
* Peak incidence at the age of 30 years old
* Peak incidence at the age of 30 years old
* Usually mixed with other types
* Usually mixed with other types
| style="background: #F5F5F5; padding: 5px;" |Early metastasis to:
| style="background: #F5F5F5; padding: 5px;" |Early [[metastasis]] to:
* retroperitoneum
* [[retroperitoneum]]
* Lung
* [[Lung]]
* Liver
* [[Liver]]
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
* CD30  
* [[CD30]]
* HCG  
* [[HCG]]
May stain positively for :
May stain positively for :
* AFP, when mixed with other tumors
* [[AFP]], when mixed with other [[tumors]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Primitive epithelial cells with marked pleomorphism
* Primitive [[epithelial cells]] with marked [[pleomorphism]]
* Often mixed histopathological features (solid, papillary, tubular, pseudoglandular)
* Often mixed [[histopathological]] features ([[solid]], [[papillary]], [[tubular]], pseudoglandular)
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |±
| style="background: #F5F5F5; padding: 5px;" |±
Line 93: Line 93:
* May present with abdominal/ pelvic mass
* May present with abdominal/ pelvic mass
* Abdominal pain may be present
* Abdominal pain may be present
* Metastatic findings
* [[Metastatic]] findings
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Elevated serum hCG
* Elevated serum hCG
Line 117: Line 117:
* Uncommon
* Uncommon
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:  
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:  
* AFP
* [[AFP]]
* Alpha-1-antitrypsin
* [[Alpha 1-antitrypsin deficiency|Alpha-1-antitrypsin]]
* PAS diastase
* [[PAS diastase]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Yellow, mucinous, encapsulated mass
* Yellow, [[mucinous]], encapsulated mass


* Schiller-Duval bodies (perivascular structures)
* Schiller-Duval bodies (perivascular structures)
Line 128: Line 128:
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Palpable mass
* [[Palpable]] [[mass]]
* Nontender mass
* Nontender mass
* Unilateral mass
* Unilateral [[mass]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Elevated serum AFP
* Elevated serum AFP
Line 154: Line 154:
* Benign form in children under 4 years old
* Benign form in children under 4 years old
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Uncommon in benign ones among prepubertal men
* Uncommon in [[benign]] ones among prepubertal men


* Common in malignant ones among postpubertal ones
* Common in [[malignant]] ones among postpubertal ones
* Metastasis may be teratomatous
* [[Metastasis]] may be teratomatous
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Chromosome 12p mutations
* [[Chromosome]] 12 [[Mutation|mutations]]
Stains positively for:
Stains positively for:
* Cytokeratin
* [[Cytokeratin]]
* HCG
* [[HCG]]
* AFP
* [[AFP]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Large, heterogeneous appearance
* Large, [[heterogeneous]] appearance
* Presence of at least 2 germ layers
* Presence of at least 2 [[germ layers]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Palpable mass
* Palpable [[mass]]
* Nontender mass
* Nontender mass
* Unilateral mass
* Unilateral mass
Line 184: Line 184:
* [[Malignant]]
* [[Malignant]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Testicular mass may be small/ asymptomatic
* [[Testicular]] mass may be small/ asymptomatic
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* History of [[cryptorchidism]]
* History of [[cryptorchidism]]
Line 190: Line 190:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Most aggressive type
* Most aggressive type
| style="background: #F5F5F5; padding: 5px;" |Early metastasis:
| style="background: #F5F5F5; padding: 5px;" |Early [[metastasis]]:
* Liver
* [[Liver]]
* Brain
* [[Brain]]
* Lung
* [[Lung]]
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
* hCG
* [[HCG]]
* Genetic changes of 12p11.2-p12.1 chromosomal region
* [[Genetic]] changes of 12p11.2-p12.1 [[chromosomal]] region
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Characterized by hemorrhagic and necrotic areas
* Characterized by [[hemorrhagic]] and [[necrotic]] areas
* Disordered syncytiotrophoblastic and cytotrophoblastic elements
* Disordered syncytiotrophoblastic and [[cytotrophoblastic]] elements
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |±
| style="background: #F5F5F5; padding: 5px;" |±
Line 225: Line 225:
* Average age about 30 years old
* Average age about 30 years old
* Rare in prepubertal age
* Rare in prepubertal age
* Include one-third of all testicular gem cell tumors
* Include one-third of all [[testicular]] [[germ cell tumors]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Metastasis depends on tumors types
* [[Metastasis]] depends on tumors types
* Metastasis to lung, liver, brain, skin
* [[Metastasis]] to [[lung]], [[liver]], [[brain]], [[skin]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* May stain positive based on underlying components
* May stain positive based on underlying components
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Variable components depends on tumor
* Variable components depends on [[tumor]]
* Accompanied with necrosis and hemorrhages  
* Accompanied with necrosis and hemorrhages  
| style="background: #F5F5F5; padding: 5px;" |±
| style="background: #F5F5F5; padding: 5px;" |±
Line 253: Line 253:
* Bilateral
* Bilateral
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Cryptorchid testes  
* Cryptorchid [[testes]]
* Previous [[testicular cancer]]
* Previous [[testicular cancer]]
* Abnormal sexual differentiation
* Abnormal sexual differentiation
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* A precursor of most testicular germ cell tumors
* A precursor of most [[testicular]] [[germ cell tumors]]
* Adjacent to a other testicular germ cell tumors > 90% of all
* Adjacent to a other [[testicular]] [[germ cell tumors]] > 90% of all
| style="background: #F5F5F5; padding: 5px;" |Common:
| style="background: #F5F5F5; padding: 5px;" |Common:
 
* [[Lymph nodes]]
Lymph nodes
* Any other [[organs]]
 
Any other organs
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Stain positively for:
Stain positively for:
* PALP
* PALP


* Genetic changes in chromosome 12  
* [[Genetic]] changes in [[chromosome 12]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Proliferation of neoplastic germ cells in seminiferous tubules
* Proliferation of [[neoplastic]] [[germ cells]] in [[seminiferous tubules]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
Line 321: Line 319:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Golden brown color
* Golden brown color
* May have cystic, hemorrhagic, or necrotic areas
* May have [[cystic]], [[hemorrhagic]], or [[necrotic]] areas
* Eosinophilic crystals of Reinke
* [[Eosinophilic]] crystals of Reinke
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
Line 356: Line 354:
* Considered as stromal tumors
* Considered as stromal tumors
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Uncommon metastasis
* Uncommon [[metastasis]]
| style="background: #F5F5F5; padding: 5px;" |Stain positively for:
| style="background: #F5F5F5; padding: 5px;" |Stain positively for:
* Inhibin
* Inhibin
* Cytokeratin
* Cytokeratin
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Solid or hollow tubules divided by basement membrane
* Solid or hollow tubules divided by [[basement membrane]]


* Pale eosinophilic cytoplasm
* Pale [[eosinophilic]] [[cytoplasm]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
Line 388: Line 386:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* The most common in men older than 50 years old
* The most common in men older than 50 years old
| style="background: #F5F5F5; padding: 5px;" |Common metastasis to :
| style="background: #F5F5F5; padding: 5px;" |Common [[metastasis]] to :
* Skin
* [[Skin]]
* Subcutaneous tissue
* [[Subcutaneous tissue]]
* Bone marrow
* [[Bone marrow]]
* Central nervous system
* [[Central nervous system]]
* Lung
* [[Lung]]
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
* CD45
* [[CD45]]


* Depends on lymphoma subtype
* Depends on [[lymphoma]] subtype
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Pleomorphic malignant cells  
* [[Pleomorphic]] [[malignant]] cells  
* Large irregular nuclei
* Large irregular [[nuclei]]
* Vascular invasion
* [[Vascular]] [[invasion]]
* Seminiferous tubules
* [[Seminiferous tubules]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Palpable mass
* [[Palpable]] mass
* Nontender mass
* Nontender mass
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Depends on lymphoma subtype
* Depends on [[lymphoma]] subtype
| style="background: #F5F5F5; padding: 5px;" |Ultrasound:
| style="background: #F5F5F5; padding: 5px;" |Ultrasound:
* Diffuse testicular infiltration and enlargement
* Diffuse testicular infiltration and enlargement
Line 433: Line 431:
* Adult type with average age of 44 years old ( rare)
* Adult type with average age of 44 years old ( rare)
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Metastasis occur in 10%-20% of cases
* [[Metastasis]] occur in 10%-20% of cases
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
| style="background: #F5F5F5; padding: 5px;" |Stains positively for:
* Calretinin
* [[Calretinin]]
* Inhibin
* [[Inhibin]]
* Vimentin,
* [[Vimentin]]
* Actin
* [[Actin]]
* MIC2
* MIC2
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Common features are microfollicular and diffuse
* Common features are microfollicular and [[diffuse]]
* Call-Exner bodies in adult type ( eosinophillic material)
* [[Call-Exner bodies]] in adult type ( eosinophillic material)
* In juvenile type: Solid sheets or nodules and  form ectatic spaces
* In juvenile type: [[Solid]] sheets or [[nodules]] and  form ectatic spaces
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Palpable mass
* [[Palpable]] mass
* Nontender mass
* Nontender mass
| style="background: #F5F5F5; padding: 5px;" |Elevated serum:
| style="background: #F5F5F5; padding: 5px;" |Elevated [[serum]]:
* Inhibin
* [[Inhibin]]
* Müllerian inhibiting hormone
* [[Müllerian inhibiting factor]]
| style="background: #F5F5F5; padding: 5px;" |Ultrasound:
| style="background: #F5F5F5; padding: 5px;" |Ultrasound:
* Hypoechoic mass
* Hypoechoic mass

Revision as of 15:06, 28 January 2019

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer differential diagnosis

CDC on Testicular cancer differential diagnosis

Testicular cancer differential diagnosis in the news

Blogs on Testicular cancer differential diagnosis

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.

Differentiating Testicular cancer from other Diseases

Testicular cancer must be differentiated from:

Diseases Benign/ Malignant Unilateral/Bilateral History Demography Metastasis Genetics Histopathology Clinical manifestations Para-clinical findings
Pain Mass Physical examination
Lab findings Imaging
Germ Cell tumors Seminoma[1][2]
  • Most common among age of 15-35 years old
  • Does not occur during infancy
Stains positively for:
  • Large cells wit watery cytoplasm
  • Fried egg appearance
- +
  • Elevated serum placental ALP (PALP)
Ultrasound:
  • Homogeneous hypoechoic intratesticular mass
  • Cysts and calcificications are uncommon
  • Inhomogenous feature in larger mass
Embryonal carcinoma[3]
  • Rare type
  • Peak incidence at the age of 30 years old
  • Usually mixed with other types
Early metastasis to: Stains positively for:

May stain positively for :

+ ±
  • Unremarkable
  • May present with abdominal/ pelvic mass
  • Abdominal pain may be present
  • Metastatic findings
  • Elevated serum hCG
  • Elevated serum AFP, when mixed with other tumor types
Ultrasound:
  • Usually hypoechoic mass
  • Invasion to tunica albuginea
  • Irregular calcifications
Yolk sac tumor[4][5]
  • Unilateral
  • Most common prepubertal testicular cancer in children < 3 years of age
  • Common among Asian
  • Uncommon
Stains positively for:
  • Schiller-Duval bodies (perivascular structures)
  • Hyaline-type globules
+ +
  • Elevated serum AFP
Ultrasound:
  • Diffuse enlargement of the testis with a heterogeneous appearance

MRI:

  • Areas of hemorrhage and necrosis
Teratoma[6][7]
  • Unilateral
History of congenital disease such as:
  • May present in both prepubertal and adult men
  • Benign form in children under 4 years old
  • Uncommon in benign ones among prepubertal men

Stains positively for:

- +
  • Palpable mass
  • Nontender mass
  • Unilateral mass
  • Elevated serum hCG
  • Elevated serum AFP
Ultrasound:
  • Heterogeneous, cystic appearance
  • Irregular calcifications
Choriocarcinoma[8][9]
  • Most aggressive type
Early metastasis: Stains positively for: + ±
  • Nonpalpable or small mass
  • Painless or radiating pain to groin/ abdomen
  • Metastatic findings
  • Gynecomastia
  • Hyperthyroidism symptoms
  • Elevated serum hCG
Ultrasound:
  • Hemorrhage and necrosis
  • May appear more cystic inhomogeneous, and calcified
Mixed germ cell tumors[10][11]
  • Unilateral
  • Two or more germ cell tumors present as a single mass
  • Depends on underlying components
  • May stain positive based on underlying components
  • Variable components depends on tumor
  • Accompanied with necrosis and hemorrhages
± +
  • Physical exam findings based on underlying components

Elevations in:

  • AFP
  • Beta-hCG
  • Imaging findings based on underlying components
Carcinoma in situ (intratubular germ cell neoplasia )[12][13][14]
  • Unilateral
  • Bilateral
Common:

Stain positively for:

  • PALP
- -
  • N/A
Elevated for:
  • PALP
  • N/A
Diseases Benign/ Malignant Unilateral/Bilateral History Demography Metastasis Genetics Histopathology Pain Mass Physical exam Lab Findings Imaging
Non- germ cell tumors Leydig cell tumor[15]
  • Unilateral
  • Slowly enlarging painless unilateral mass
  • Based on large size, vascular invasion, and mitotic activity classify into benign / malignant
  • Bimodal age distribution in both adults and children
  • Considered as stromal tumors
  • Uncommon metastasis
  • Mutation in fumarate hydratase

Stains positively for:

  • inhibin-A
  • Calretinin
  • WT-1
  • SALL-4
- +
  • Palpable mass
  • Unilateral mass
  • Nontender
  • Gynecomastia
  • N/A
Ultrasound:
  • Well-defined, hypoechoic solid mass
  • Cystic component
  • Irregular calcifications
Sertoli cell tumor[16][17][18]
  • Unilateral
  • Bilateral
  • Occur in any ages (infancy to elderly)
  • Average age of 45 years
  • Mean age for large cell calcifying variant is 21 years old
  • 0.1% of testicular tumors
  • Considered as stromal tumors
Stain positively for:
  • Inhibin
  • Cytokeratin
- +
  • Palpable and painless mass
  • Hyperestrinism is noted in syndromic cases
  • Gynecomastia
  • N/A
Ultrasound:
  • Large cell calcifying variant
  • Hypoechoic
Testicular lymphoma[19][20][21]
  • Unilateral
  • Bilateral ( mostly up to 35% of cases)
  • The most common in men older than 50 years old
Common metastasis to : Stains positively for: - + Ultrasound:
  • Diffuse testicular infiltration and enlargement
  • Hypervascularity
  • Hypoechoic and solid lesion
Granulosa cell tumors[22][23]
  • Unilateral

Juvenile type associated with:

  • Similar to ovarian counterparts
  • Occur in both adult and juvenile
  • Juvenile type in children less than 2 years old ( the most common infancy tumor)
  • Adult type with average age of 44 years old ( rare)
Stains positively for: - + Elevated serum: Ultrasound:
  • Hypoechoic mass
  • Solid and cystic appearance

References

  1. Siegel RL, Miller KD, Jemal A (2016). "Cancer statistics, 2016". CA Cancer J Clin. 66 (1): 7–30. doi:10.3322/caac.21332. PMID 26742998.
  2. Miller FH, Whitney WS, Fitzgerald SW, Miller EI (1999). "Seminomas complicating undescended intraabdominal testes in patients with prior negative findings from surgical exploration". AJR Am J Roentgenol. 172 (2): 425–8. doi:10.2214/ajr.172.2.9930796. PMID 9930796.
  3. Ishida M, Hasegawa M, Kanao K, Oyama M, Nakajima Y (2009). "Non-palpable testicular embryonal carcinoma diagnosed by ultrasound: a case report". Jpn J Clin Oncol. 39 (2): 124–6. doi:10.1093/jjco/hyn141. PMID 19066212.
  4. Howitt BE, Berney DM (2015). "Tumors of the Testis: Morphologic Features and Molecular Alterations". Surg Pathol Clin. 8 (4): 687–716. doi:10.1016/j.path.2015.07.007. PMID 26612222.
  5. Magers MJ, Kao CS, Cole CD, Rice KR, Foster RS, Einhorn LH; et al. (2014). ""Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin". Am J Surg Pathol. 38 (10): 1396–409. doi:10.1097/PAS.0000000000000262. PMID 24921638.
  6. Simmonds PD, Lee AH, Theaker JM, Tung K, Smart CJ, Mead GM (1996). "Primary pure teratoma of the testis". J Urol. 155 (3): 939–42. PMID 8583612.
  7. Brosman SA (1979). "Testicular tumors in prepubertal children". Urology. 13 (6): 581–8. PMID 377749.
  8. Puri S, Sood S, Mohindroo S, Kaushal V (2015). "Cytomorphology of lung metastasis of pure choriocarcinoma of testis in a 58-year-old male". J Cancer Res Ther. 11 (4): 1035. doi:10.4103/0973-1482.154010. PMID 26881635.
  9. Wood HM, Elder JS (2009). "Cryptorchidism and testicular cancer: separating fact from fiction". J Urol. 181 (2): 452–61. doi:10.1016/j.juro.2008.10.074. PMID 19084853.
  10. Chuang KL, Liaw CC, Ueng SH, Liao SK, Pang ST, Chang YH; et al. (2010). "Mixed germ cell tumor metastatic to the skin: case report and literature review". World J Surg Oncol. 8: 21. doi:10.1186/1477-7819-8-21. PMC 2851696. PMID 20331874.
  11. Krag Jacobsen G, Barlebo H, Olsen J, Schultz HP, Starklint H, Søgaard H; et al. (1984). "Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases". Acta Radiol Oncol. 23 (4): 239–47. PMID 6093440.
  12. Rajpert-De Meyts E, Skakkebaek NE (1994). "Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours". Int J Androl. 17 (2): 85–92. PMID 7517917.
  13. Jacobsen GK, Nørgaard-Pedersen B (1984). "Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study". Acta Pathol Microbiol Immunol Scand A. 92 (5): 323–9. PMID 6209917.
  14. Jacobsen GK, Henriksen OB, von der Maase H (1981). "Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors: a study of 105 cases". Cancer. 47 (11): 2660–2. PMID 7260858.
  15. Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM (1998). "Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors". Am J Surg Pathol. 22 (11): 1361–7. PMID 9808128.
  16. Banerji JS, Odem-Davis K, Wolff EM, Nichols CR, Porter CR (2016). "Patterns of Care and Survival Outcomes for Malignant Sex Cord Stromal Testicular Cancer: Results from the National Cancer Data Base". J Urol. 196 (4): 1117–22. doi:10.1016/j.juro.2016.03.143. PMID 27036305.
  17. Young RH (2005). "Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems". Mod Pathol. 18 Suppl 2: S81–98. doi:10.1038/modpathol.3800311. PMID 15502809.
  18. Gabrilove JL, Freiberg EK, Leiter E, Nicolis GL (1980). "Feminizing and non-feminizing Sertoli cell tumors". J Urol. 124 (6): 757–67. PMID 7003168.
  19. Shahab N, Doll DC (1999). "Testicular lymphoma". Semin Oncol. 26 (3): 259–69. PMID 10375083.
  20. Kim J, Abu-Yousef M (2013). "Testicular lymphoma". Ultrasound Q. 29 (3): 247–8. doi:10.1097/RUQ.0b013e3182a0ac0e. PMID 23945480.
  21. Vega F, Medeiros LJ, Abruzzo LV (2001). "Primary paratesticular lymphoma: a report of 2 cases and review of literature". Arch Pathol Lab Med. 125 (3): 428–32. doi:10.1043/0003-9985(2001)125<0428:PPL>2.0.CO;2. PMID 11231498.
  22. Garrett JE, Cartwright PC, Snow BW, Coffin CM (2000). "Cystic testicular lesions in the pediatric population". J Urol. 163 (3): 928–36. PMID 10688023.
  23. Ditonno P, Lucarelli G, Battaglia M, Mancini V, Palazzo S, Trabucco S; et al. (2007). "Testicular granulosa cell tumor of adult type: a new case and a review of the literature". Urol Oncol. 25 (4): 322–5. doi:10.1016/j.urolonc.2006.08.019. PMID 17628299.


Template:WikiDoc Sources